Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019?
- PMID: 32371813
- PMCID: PMC7236847
- DOI: 10.1097/HJH.0000000000002474
Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019?
Conflict of interest statement
There are no conflicts of interest.
Comment on
-
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?J Hypertens. 2020 May;38(5):781-782. doi: 10.1097/HJH.0000000000002450. J Hypertens. 2020. PMID: 32195824 No abstract available.
References
-
- Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? J Hypertens 2020; 38:781–782. - PubMed
-
- Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005; 111:2605–2610. - PubMed
-
- Bavishi C, Bangalore S, Messerli FH. Renin angiotensin aldosterone system inhibitors in hypertension: is there evidence for benefit independent of blood pressure reduction? Prog Cardiovasc Dis 2016; 59:253–261. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
